Daniel On-Fai Lee MD FAASM, FAAN

Neurophysiology, Sleep Medicine

Professor, Department of Neurology, UK HealthCare

Summary

Dr. Daniel Lee is a neurologist in Lexington, KY. He received his medical degree from University of Kentucky College of Medicine and Neurology residency at Washington University Barnes Hospital and fellowship in sleep medicine at Stanford School of Sleep Medicine. His practice include sleep medicine, general neurology, and headache disorders. His research interest include D3 knock out models, RLS treatment trial, TBI treatment trial, Alpha synuclein biomarker in saliva characterization, atrial remodeling in OSA.

Stanford Health Care-Sponsored Stanford UniversityFellowship, Clinical Neurophysiology, 1993
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 1988 - 1992
TriHealth (Good Samaritan Hospital)Internship, Internal Medicine, 1988 - 1989
Boston City HospitalMD, Externship, Neurology, 1987 - 1988
University of Kentucky College of MedicineClass of 1988, MD, Honor

PubMed

7 citations
The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome
Alon Y. Avidan, Daniel Lee, Margaret Park, Mark J. Jaros, Gwendoline Shang
CNS Drugs. 2016-04-11
9 citations
Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
Daniel O. Lee, Mark J. Buchfuhrer, Diego Garcia-Borreguero, Alon Y. Avidan, Mansoor Ahmed
Sleep Medicine. 2016-03-01
26 citations
Personality correlates of adherence with continuous positive airway pressure (CPAP)
Alicia M. Moran, Daniel Erik Everhart, Claude Ervin Davis, Karl L. Wuensch, Daniel O. Lee
Sleep & Breathing = Schlaf & Atmung. 2011-12-01

Journal Articles

Cardiovascular Risks Among Restless Legs Syndrome Patients
Lee D, Wake County Medical Journal, 1/1/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome
D. Lee, R. Ziman, T.Perkins, S. Poceta, A.Walters, R. Barrett, Journal of Clinical Sleep Medicine, 6/1/2011
Personality Correlates of Adherence with Continuous Positive Airway Pressure Treatment Predicting CPAP Compliance using the Behavioral Inhibition System (BIS) and Beh...
S.Moran, D.Everhart, C.Davis, D.Lee, Wuensch, K, Demare H, Sleep Breath, 9/28/2010

Abstracts/Posters

Ropinirole CR Efficacy after Overnight Switch from IR.
Lee D, Associated Professional Sleep Societies Meeting, American Academy of Neurology, MN, 2007; Boston, MA, 2007, 6/1/2007
Ropinirole IR Efficacy in Evening and Nighttime symptoms.
Lee D, American Academy of Neurology, San Diego, CA, 5/1/2006
Ropinirole IR Efficacy Poster Regardless of Age of Onset.
Lee D, American Geriatric Society, 1/1/2006

Lectures

Alteration of circadian rhythm in the 3XTg mouse model of Alzheimer disease.
Greenville, NC - 11/6/2012
Restless Legs Syndrome. From Bedside to Bench side and Back.
Friday Center, Chapel Hill, NC - 11/1/2011
Lord of the Dopamine Receptors: Critical Role of D3 in sensory-motor and autonomic function.
11/1/2011

Other

Alzheimer's disease.
Lee D, NC Public Television Broadcast, Duke University Faculty panel discussion
1/1/2003

Visa Delays Threaten July 1 Start for Incoming Medical Residents in Alabama: Op-EdJune 10th, 2025
New Sanders-Brown Center on Aging Memory Clinic Expanding Research and Enhancing Patient CareJanuary 11th, 2022
Rockcastle Native Recovering from Severe Neurological Impacts Following COVID-19March 17th, 2021